[go: up one dir, main page]

RU2003137600A - Крем для лечения солнечных ожогов - Google Patents

Крем для лечения солнечных ожогов Download PDF

Info

Publication number
RU2003137600A
RU2003137600A RU2003137600/15A RU2003137600A RU2003137600A RU 2003137600 A RU2003137600 A RU 2003137600A RU 2003137600/15 A RU2003137600/15 A RU 2003137600/15A RU 2003137600 A RU2003137600 A RU 2003137600A RU 2003137600 A RU2003137600 A RU 2003137600A
Authority
RU
Russia
Prior art keywords
cream
lipoic acid
active ingredients
coenzyme
acetyl
Prior art date
Application number
RU2003137600/15A
Other languages
English (en)
Other versions
RU2313333C2 (ru
Inventor
Йохан АНДЕРССОН (SE)
Йохан АНДЕРССОН
Ульф СТАРЛАНДЕР (SE)
Ульф СТАРЛАНДЕР
Бьорн АНДЕРССОН (SE)
Бьорн АНДЕРССОН
Original Assignee
Макронова АБ (SE)
Макронова АБ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Макронова АБ (SE), Макронова АБ filed Critical Макронова АБ (SE)
Publication of RU2003137600A publication Critical patent/RU2003137600A/ru
Application granted granted Critical
Publication of RU2313333C2 publication Critical patent/RU2313333C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Claims (4)

1. Крем для наружного лечения видимых солнечных повреждений, вызванных процессами, включающими в себя воздействие свободных радикалов, активные ингредиенты которого находятся в стабилизирующей основе для крема, отличающийся тем, что 0,5-7 мас.% D,L-α-липоевой кислоты, 0,05-0,5 мас.% кофермента Q-10 и 0,01-3 мас.% ацетил-L-карнитина гидрохлорида составляют эти активные ингредиенты.
2. Крем по п.1, отличающийся тем, что он содержит 5 мас.% D,L-α-липоевой кислоты, 0,3 мас.% кофермента Q-10 и 0,03 мас.% ацетил-L-карнитина гидрохлорида.
3. Крем по п.1, отличающийся тем, что он содержит 1 мас.% D,L-α-липоевой кислоты, 0,3% масс. кофермента Q-10 и 0,03% масс. ацетил-L-карнитина гидрохлорида.
4. Способ приготовления крема, содержащего D,L-a-липоевую кислоту, отличающийся тем, что перед смешиванием с остальными компонентами данного крема активный ингредиент, представляющий собой D,L-α-липоевую кислоту, растворяют в каприловом/каприновом триглицериде, после чего указанную смесь D,L-α-липоевой кислоты и каприлового/капринового триглицерида добавляют к основе для крема.
RU2003137600/15A 2001-07-02 2002-06-30 Крем для лечения кожи, поврежденной солнцем RU2313333C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102380A SE0102380D0 (sv) 2001-07-02 2001-07-02 Kräm för behandling av åldersförändringar i huden hos människa
SE0102380-3 2001-07-02

Publications (2)

Publication Number Publication Date
RU2003137600A true RU2003137600A (ru) 2005-03-27
RU2313333C2 RU2313333C2 (ru) 2007-12-27

Family

ID=20284723

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003137600/15A RU2313333C2 (ru) 2001-07-02 2002-06-30 Крем для лечения кожи, поврежденной солнцем

Country Status (20)

Country Link
US (2) US20050152856A2 (ru)
EP (1) EP1411889B1 (ru)
JP (1) JP2005507406A (ru)
KR (1) KR100885347B1 (ru)
CN (1) CN1713888B (ru)
AT (1) ATE349998T1 (ru)
AU (1) AU2002318699B2 (ru)
BR (1) BR0210760A (ru)
CA (1) CA2450726A1 (ru)
CY (1) CY1107600T1 (ru)
DE (1) DE60217356T2 (ru)
DK (1) DK1411889T3 (ru)
ES (1) ES2280554T3 (ru)
MX (1) MXPA03011509A (ru)
NO (1) NO20035715D0 (ru)
NZ (1) NZ530226A (ru)
PT (1) PT1411889E (ru)
RU (1) RU2313333C2 (ru)
SE (1) SE0102380D0 (ru)
WO (1) WO2003037291A1 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2858932B1 (fr) * 2003-08-22 2009-10-30 Oreal Composition destinee a lutter contre la degradation des fibres de collagene induite en condition d'exposition solaire naturelle
ES2631152T3 (es) 2004-01-22 2017-08-28 University Of Miami Formulaciones de coenzima Q10 tópicas o intravenosas para su uso en el tratamiento del cáncer
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
CN1723881A (zh) * 2005-06-23 2006-01-25 马开龙 含辅酶q10的治疗皮肤病的组合物及其制备方法
CA2823407C (en) 2007-03-22 2016-10-18 Berg Pharma Llc Topical formulations having enhanced bioavailability
US7999040B2 (en) * 2007-09-25 2011-08-16 Nanochem Solutions, Inc. Method of making graft copolymers from sodium poly(aspartate) and the resulting graft copolymer
WO2009145982A1 (en) * 2008-04-01 2009-12-03 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
EP2271325A4 (en) 2008-04-11 2011-11-09 Cytotech Labs Llc METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS
KR101553074B1 (ko) 2008-07-17 2015-09-14 가천대학교 산학협력단 나노에멀젼 조성물
US10519504B2 (en) 2009-05-11 2019-12-31 Berg Llc Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
US11400058B2 (en) 2010-03-12 2022-08-02 Berg Llc Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof
EP2694463B8 (en) 2011-04-04 2019-10-09 Berg LLC Treating central nervous system tumors with coenzyme q10
EA201490047A1 (ru) 2011-06-17 2014-08-29 Берг Ллк Ингаляционные фармацевтические композиции
EA032775B1 (ru) 2013-04-08 2019-07-31 Берг Ллк Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
WO2015035094A1 (en) 2013-09-04 2015-03-12 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
WO2020201377A1 (en) 2019-04-04 2020-10-08 Medica Clinical Nord Sverige Ab Cream for treatment of skin injured by the sun
SE543528C2 (en) * 2019-04-04 2021-03-16 Medica Clinical Nord Sverige Ab Cream for treatment of skin injured by the sun
CN119950732A (zh) * 2023-11-09 2025-05-09 福州大学 一种纳米药物透皮递送系统及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62175415A (ja) * 1986-01-27 1987-08-01 Kanebo Ltd 皮膚化粧料
JP2794433B2 (ja) * 1989-02-02 1998-09-03 丸善製薬株式会社 甘草疎水性フラボノイド製剤
DE4410238A1 (de) * 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
RU2116778C1 (ru) * 1995-03-03 1998-08-10 Сергей Сергеевич Автушенко Косметическая композиция
WO1997002041A1 (en) * 1995-07-03 1997-01-23 Crandall Wilson T Transdermal and oral treatment of androgenic alopecia
DE19537027A1 (de) * 1995-10-05 1997-04-10 Beiersdorf Ag Hautpflegemittel für alte Haut
US5667791A (en) 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6015548A (en) * 1998-07-10 2000-01-18 Shaklee Corporation High efficiency skin protection formulation with sunscreen agents and antioxidants
DE19806889A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Verwendung von Acyl-Carnitin
DE19806947A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US6013270A (en) * 1998-04-20 2000-01-11 The Procter & Gamble Company Skin care kit
AU756691B2 (en) * 1998-04-24 2003-01-23 Procter & Gamble Company, The Cleansing articles for skin and/or hair which also deposits skin care actives
JP2000063273A (ja) * 1998-08-20 2000-02-29 Noevir Co Ltd 免疫機能低下抑制剤
IT1302307B1 (it) * 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
US6048886A (en) 1998-10-05 2000-04-11 Neigut; Stanley Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin
PL190755B1 (pl) * 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
IT1312377B1 (it) * 1999-03-05 2002-04-15 Uni Ci S R L Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US20020044913A1 (en) 2000-02-11 2002-04-18 Hamilton Nathan D. Cosmetics to support skin metabolism
DE10020874A1 (de) * 2000-04-28 2001-05-17 Murnauer Markenvertrieb Gmbh Kosmetisch-pharmazeutisches Kombinationspräparat
EP1294353B1 (en) * 2000-06-06 2006-03-22 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
DE10036797A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Verwendung von Kombinationen mit einem Gehalt an Carnitinen
DE10036798A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Mittel zur Behandlung der Haare und der Kopfhaut
DE10059584A1 (de) * 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US20020119114A1 (en) * 2000-12-18 2002-08-29 Beiersdorf Aktiengesellschaft Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
DE10111048A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von alpha-Liponsäure zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Regeneration beanspruchter Haut, insbesondere der gealterten Haut
US20030167556A1 (en) * 2002-03-05 2003-09-11 Consumers Choice Systems, Inc. Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging

Also Published As

Publication number Publication date
WO2003037291A1 (en) 2003-05-08
DE60217356T2 (de) 2007-10-11
US20050152856A2 (en) 2005-07-14
US20040219114A1 (en) 2004-11-04
DE60217356D1 (de) 2007-02-15
BR0210760A (pt) 2004-07-20
KR20040030728A (ko) 2004-04-09
AU2002318699B2 (en) 2007-01-04
NZ530226A (en) 2005-08-26
WO2003037291A8 (en) 2004-05-13
ATE349998T1 (de) 2007-01-15
EP1411889A1 (en) 2004-04-28
MXPA03011509A (es) 2004-10-28
CY1107600T1 (el) 2013-03-13
PT1411889E (pt) 2007-04-30
RU2313333C2 (ru) 2007-12-27
US20070212431A1 (en) 2007-09-13
ES2280554T3 (es) 2007-09-16
JP2005507406A (ja) 2005-03-17
CA2450726A1 (en) 2003-05-08
CN1713888A (zh) 2005-12-28
DK1411889T3 (da) 2007-05-07
NO20035715D0 (no) 2003-12-19
SE0102380D0 (sv) 2001-07-02
EP1411889B1 (en) 2007-01-03
CN1713888B (zh) 2011-01-26
KR100885347B1 (ko) 2009-02-26

Similar Documents

Publication Publication Date Title
RU2003137600A (ru) Крем для лечения солнечных ожогов
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
WO2004060314A3 (en) Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
IT1288290B1 (it) Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
EP1570840A3 (en) Topical composition comprising n-acetylaldosamines or n-acetylamino acids
WO2003013497A1 (en) Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
NZ541593A (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
RU2009117468A (ru) Наружный препарат для кожи
WO2001095856A3 (en) Urea derivative useful as an anti-cancer agent and process for preparing same
IL158082A0 (en) Amlodipine camsylate and methods for the preparation thereof
MX2023009052A (es) Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo.
WO2004032873A3 (en) Therapeutic combination of carnitine and antioxidant polyphenols
WO2004089329A3 (en) Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
CA2359491A1 (en) Mixture of plant treatment compositions with waxes, their preparation, and their use
DK1115697T3 (da) Umættede hydroximsyrederivater som PARP-inhibitorer
ATE383332T1 (de) Alpha-ketoglutarate von wirkstoffen und deren zusammensetzungen
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
RU2002118730A (ru) Препарат для местного применения при лечении туберкулеза легких и гнойно-воспалительных заболеваний
CA2355779A1 (en) Improved release of medicament active agents from a chewing gum coating
WO2002098843A3 (en) Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
WO2003000700A3 (en) Ascorbyl derivatives of carnitines and cosmetic compositions containing same
ATE337776T1 (de) Kosmetische oder dermatologische cremezubereitung,deren herstellung und verwendung
AR008764A1 (es) Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.
IT8322238A0 (it) Sali di endo-8,8-dialchil-8-azoniabiciclo [3.2.1.] ottan-6,7-eso-epossi-3-alchilcarbossilati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo
TW200600012A (en) Fungicidal mixtures

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20110701